Navigation Links
Clostridium difficile Infection: Tracking a Virulent Pathogen

VOORHEES, N.J., Aug. 13 /PRNewswire/ -- The rates and severity of Clostridium difficile infection (CDI) may be impacted by several factors, including antimicrobial use, other drug-prescribing factors, infection control practices, and the presence of a new strain of C. difficile that is more resistant to fluoroquinolones and associated with higher rates of morbidity and mortality. It is crucial for healthcare professionals to be aware of these factors and apply evidence-based practices for the prevention, diagnosis, and treatment of CDI.

To address the need for current education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture entitled Clostridium difficile Infection: Tracking a Virulent Pathogen. The content of this virtual lecture is based on a live symposium that took place on Wednesday, June 10, 2009, during the 36th Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) Annual Conference. This activity is supported by an educational grant from ViroPharma Incorporated.

Faculty for this program are experts in infection control and gastroenterology, including Stuart Johnson, MD, DTM&H; Dale N. Gerding, MD, FACP, FIDSA; Ciaran P. Kelly, MD; and Keith S. Kaye, MD, MPH.

Healthcare professionals can visit to access this complimentary continuing education virtual lecture.

"Robert Michael Educational Institute LLC is committed to providing healthcare professionals with opportunities for quality, innovative, and convenient continuing medical education," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment, leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit

SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
2. Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
3. Transmission of MRSA and Clostridium difficile through dogs
4. Clostridium difficile Infection in Primary Care: Tackling a Virulent Pathogen
5. Interview with GI Experts: Discussions in Clostridium difficile
6. Clostridium difficile Infection: Best Strategies for Care of Older Adults
7. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
8. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
9. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
10. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
11. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... of Toronto and the University of British Columbia suggested that laws requiring bicyclists to ... article explains that part of the reason for the controversial conclusion is that, while ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in ... (see Table 1-1 ). More than 3.7 billion people under the age of ... 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
Breaking Medicine Technology: